Clomiphene Citrate
Clomiphene Citrate structure
|
Common Name | Clomiphene Citrate | ||
|---|---|---|---|---|
| CAS Number | 50-41-9 | Molecular Weight | 598.083 | |
| Density | N/A | Boiling Point | 509ºC at 760 mmHg | |
| Molecular Formula | C32H36ClNO8 | Melting Point | 116.5-118°C | |
| MSDS | Chinese USA | Flash Point | 261.6ºC | |
| Symbol |
GHS08 |
Signal Word | Warning | |
|
Aberrant endocrinology and ovarian response to clomiphene citrate during the course of an undiagnosed early intrauterine pregnancy: a case report.
J. Reprod. Med. 58(5-6) , 256-60, (2013) This is an unusual case of embryonic exposure to clomiphene citrate (CC) in the setting of an undiagnosed early pregnancy with successful follicular response to CC and progression of pregnancy despite markedly attenuated serum progesterone and estradiol level... |
|
|
[Current approach to therapy for male infertility in patients with varicocele].
Ter. Arkh. 84(10) , 56-61, (2012) To improve the results of treatment for male infertility in patients with varicocele and to evaluate the efficiency of microsurgical varicocelectomy performed by the same surgeon in a large group of patients.1127 infertile males aged 22 to 52 years (mean 29.6... |
|
|
Probability of success of conservative treatment of infertility: exact timing as an important prognostic factor.
J. Reprod. Med. 58(5-6) , 205-11, (2013) To find out which forms of conservative infertility therapy led to the highest pregnancy rate and which factors influence the occurrence of a pregnancy.A total of 433 conservative treatment cycles were retrospectively evaluated. Ovarian stimulation was perfor... |
|
|
Modified repeated intracyclic clomiphene citrate therapy after conventional clomiphene therapy.
Clin. Exp. Obstet. Gynecol. 39(3) , 317-20, (2012) We compared modified repeated intracyclic clomiphene citrate therapy (RICCT) to gonadotropin therapy to determine whether this modified regimen was an effective alternative after conventional clomiphene therapy.Patients with ovulation disorder received treatm... |
|
|
Sequential clomiphene citrate/hMG versus hMG for ovulation induction in clomiphene citrate-resistant women.
Arch. Gynecol. Obstet. 287(3) , 591-7, (2013) This study was designed to compare sequential clomiphene citrate/hMG regimen to hMG regimen for ovulation induction in clomiphene citrate-resistant women.A comparative prospective study.Ninety infertile women were randomized to receive either sequential CC/hM... |
|
|
Polycystic ovarian syndrome management options.
Obstet. Gynecol. Clin. North Am. 39(4) , 495-506, (2012) Polycystic ovarian syndrome (PCOS) is a disorder of androgen excess and ovarian dysfunction. Hirsutism and elevated free testosterone levels are the most consistent signs of the androgen excess. Irregular, infrequent, or absent menses and infertility are symp... |
|
|
Evaluation and treatment of anovulatory and unexplained infertility.
Obstet. Gynecol. Clin. North Am. 39(4) , 507-19, (2012) Anovulatory disorders are a primary cause of female infertility. Polycystic ovarian syndrome is the major cause of anovulation and is generally associated with obesity. Lifestyle changes to encourage weight loss are the initial therapy for overweight and obes... |
|
|
Holoprosencephaly in clomiphene-induced pregnancy: a possible association? A case report and literature review.
Clin. Exp. Obstet. Gynecol. 39(4) , 535-6, (2012) Clomiphene is widely used for inducing ovulation. Evidence for congenital abnormalities, in particular central nervous system defects (CNS-D) and in babies born from clomiphene-induced pregnancies is conflicting. The authors report a case of holoprosencephali... |
|
|
Risk factors associated with craniosynostosis: a case control study.
Pediatr. Neurosurg. 48(3) , 152-6, (2012) Craniosynostosis is a relatively common congenital abnormality. The underlying etiology and most probable risk factors of nonsyndromic craniosynostosis are unknown. We conducted a study to identify the risk factors for craniosynostosis.In this case-control pr... |
|
|
Use of clomiphene citrate in the University of Utah Community Clinics.
J. Reprod. Med. 58(5-6) , 229-33, (2013) To determine patterns of usage of clomiphene citrate (CC) by primary care providers (obstetrician-gynecologists, family physicians, and other providers) within University of Utah Community Clinics.We performed a retrospective chart review (n = 79) and followu... |